Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system

Trends in Pharmacological Sciences

Volumn 24, Issue 1, 2003, Pages 30-35

  Katugampola, Sidath ^a   Davenport, Anthony ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GHRELIN; LIGAND;

BINDING AFFINITY; BIOINFORMATICS; CARDIOVASCULAR SYSTEM; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; GTP-BINDING PROTEINS; HUMANS; RECEPTORS, CELL SURFACE;

EID: 0037215631     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)00007-X     Document Type: Review

References (59)

1. Wilson S., Bergsma D. Orphan G-protein coupled receptors: novel drug targets for the pharmaceutical industry. Drug Des. Discov. 17:2000;105-114.
2. Marchese A., et al. Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology. Trends Pharmacol. Sci. 20:1999;370-375.
3. Civelli O., et al. Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors. Trends Neurosci. 24:2001;230-237.
4. Howard A.D., et al. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol. Sci. 22:2001;132-140.
5. Lee D.K., et al. Orphan G protein coupled receptors in the CNS. Curr. Opin. Pharmacol. 1:2001;31-39.
6. 1)apelin-13 is a novel radioligand for localising the APJ orphan receptor in human and rat tissue with evidence for a vasoconstrictor role in man. Br. J. Pharmacol. 132:2001;1255-1260.
7. 9]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis. Br. J. Pharmacol. 134:2001;143-149.
8. Katugampola S.D., et al. Discovery of recently adopted orphan receptors for apelin, urotensin-II and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. Can. J. Physiol. Pharmacol. 80:2002;1-6.
9. Lee D.K., et al. Characterization of apelin, the ligand for the APJ receptor. J. Neurochem. 74:2000;34-41.
10. Raddatz R., et al. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J. Biol. Chem. 275:2000;32452-32459.
11. Lin B., et al. Nociceptin receptor activation produces nitric oxide-mediated systemic hypotension. Life Sci. 66:2000;PL99-P104.
12. Chen C.T., et al. Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R692-R697.
13. Ames R.S., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 401:1999;282-286.
14. Sullivan K.A., et al. Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors. Biochem. Biophys. Res. Commun. 233:1997;823-828.
15. Lee D.K., et al. Discovery of a receptor related to the galanin receptors. FEBS Lett. 446:1999;103-107.
16. Ohtaki T., et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 411:2001;613-617.
17. Wang J.H., Hewick R.M. Proteomics in drug discovery. Drug Discov. Today. 4:1999;129-133.
18. Strohman R. Epigenesis: the missing beat in biotechnology? Nat. Biotechnol. 12:1994;156-164.
19. Lembo P.M., et al. Proenkephalin A gene products activate a new family of sensory neuron - Specific GPCRs. Nat. Neurosci. 5:2002;201-209.
20. Tatemoto K., et al. Isolation and characterisation of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251:1998;471-476.
21. Maguire J.J., et al. Orphan-receptor ligand human urotensin II: receptor localisation in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br. J. Pharmacol. 131:2000;441-446.
22. Ivell R. Endocrinology. This hormone has been relaxing too long! Science. 127:2002;637-638.
23. Tan Y.Y., et al. Quantitative autoradiography studies of relaxin binding in rat atria, uterus and cerebral cortex: characterisation and effects of oestrogen treatment. Br. J. Pharmacol. 127:1999;91-98.
24. Maguire J.J., Davenport A.P. Is urotensin-II the new endothelin? Br. J. Pharmacol. 137:2002;579-588.
25. Flohr S., et al. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J. Med. Chem. 25:2002;1799-1805.
26. Kojima M., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:1999;656-660.
27. Muccioli G., et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol. 440:2002;235-254.
28. Wiley K.E., Davenport A.P. Comparison of vasodilators in human mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br. J. Pharmacol. 136:2002;1146-1152.
29. Chemelli R.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
30. Szabo Z., et al. Use of positron emission tomography to study AT1 receptor regulation in vivo. J. Am. Soc. Nephrol. 12:2001;1350-1358.
31. Reinscheid R.K., et al. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science. 270:1995;792-794.
32. Sakurai T., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
33. Hinuma S., et al. A prolactin-releasing peptide in the brain. Nature. 393:1998;272-276.
34. Chambers J., et al. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature. 400:1999;261-265.
35. Feighner S.D., et al. Receptor for motilin identified in the human gastrointestinal system. Science. 284:1999;2184-2188.
36. Usdin T.B., et al. TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat. Neurosci. 2:1999;941-943.
37. Howard A.D., et al. Identification of receptors for neuromedin U and its role in feeding. Nature. 406:2000;70-74.
38. An S., et al. Identification and characterization of a melanin-concentrating hormone receptor. Proc. Natl Acad. Sci. USA. 98:2001;7576-7581.
39. Lewis K., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl Acad. Sci. USA. 98:2001;7570-7575.
40. Hsu S.Y., et al. Activation of orphan receptors by the hormone relaxin. Science. 295:2002;671-674.
41. Hosoya M., et al. Molecular and functional characteristics of APJ: tissue distribution of mRNA and interaction with endogenous ligand, apelin. J. Biol. Chem. 275:2000;21061-21067.
42. Satoh F., et al. Characterization and distribution of prolactin releasing peptide (PrRP) binding sites in the rat - Evidence for a novel binding site subtype in cardiac and skeletal muscle. Br. J. Pharmacol. 129:2000;1787-1793.
43. Hill J., et al. Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J. Biol. Chem. 276:2001;20125-20129.
44. Strunz A., et al. Analysis of the motor effects of 13-norleucine motilin on the rabbit, guineapig, rat, and human alimentary tract in-vitro. Gastroenterology. 68:1975;1485-1491.
45. Perrin M.H., Vale W.W. Corticotropin releasing factor receptors and their ligand family. Ann. New York Acad. Sci. 885:1999;312-328.
46. Salis M.B., et al. Studies of the cardiovascular effects of nociceptin and related peptides. Peptides. 21:2000;985-993.
47. Arihara Z., et al. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides. 21:2000;565-570.
48. Takahashi K., et al. Melanin-concentrating hormone in human and rat. Neuroendocrinology. 61:1995;493-498.
49. Christofides N.D., et al. Release of motilin by oral and intravenous nutrients in man. Gut. 20:1979;102-106.
50. Totsune K., et al. Role of urotensin II in patients on dialysis. Lancet. 358:2001;810-811.
51. Fawzi A.B., et al. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors. Eur. J. Pharmacol. 336:1997;233-242.
52. Langmead C.J., et al. Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor. Br. J. Pharmacol. 131:2000;683-688.
53. Miller P., et al. Motilin receptors in the human antrum. Am. J. Physiol. Gastrointest. Liver Physiol. 278:2000;G18-G23.
54. Higelin J., et al. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors. Neuropharmacology. 40:2001;114-122.
55. Burnside J.L., et al. Species differences in the efficacy of compounds at the nociceptin receptor (ORL1). Peptides. 21:2000;1147-1154.
56. Smart D., et al. The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors. Br. J. Pharmacol. 129:2000;1289-1291.
57. + signalling induced by motilin and erythromycin in the circular smooth muscle of human colon. Neurogastroenterol. Motil. 13:2001;27-35.
58. Kotani M., et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem. 276:2001;34631-34636.
59. Hsu S.Y., Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7:2001;605-611.